authors request that the sequence shown in Fig. 2 of the original report should be corrected as follows. As shown schematically here in Fig. 1 A, nucleotides 1452-1504 of the original report have to be replaced by a novel sequence shown here in Fig. 1B. This correction pertains to the 5Ј-flanking region of the gene and does not affect the coding region nor any of the conclusions drawn in the original report. The fact that there was a missing sequence element was discovered and pointed out to us by Tracy L. Bale in the laboratory of Daniel M. Dorsa, Departments of Psychiatry and Behavioral Sciences and Pharmacology, University of Washington, Seattle. As illustrated in Fig. 1 A, the novel sequence has to be inserted at the location of a dinucleotide repeat, (GT) 26 , located 89 nucleotides 5Ј to the main transcriptional initiation site. Resequencing of a newly generated phage subclone as well as Southern blot and PCR analyses (not shown) confirmed that the sequence presented here is indeed part of the genomic sequence. Since this novel sequence element is itself flanked by two dinucleotide repeats, (GT) 20 and (GT) 24 , respectively, a likely explanation is that this segment was spliced out during subcloning due to recombination between the two dinucleotide repeats. This idea is further supported by the fact that dinucleotide repeats that have the potential of forming Z-DNA structures have been shown to enhance recombination in extrachromosomal DNA up to 20-fold (1). Despite the recurrence of dinucleotide repeats around chromosomal rearrangement breakpoints, their role in mediating recombination on intact chromosomes remains, however, uncertain (2).We thank Tracy L. Bale and Daniel M. Dorsa for pointing out the error and for their help and collaboration in its correction. Fig. 3, A and C, are of (M ϩ 33H) 33ϩ .17. Mariman, E. C. M., Broers, C. A. M., Claesen, C. A.
A novel property of the bacterial outer membrane protein T, OmpT, has been discovered. It is active under extreme denaturing conditions. This finding emerged during characterization of a protease associated with the degradation of recombinant proteins expressed as inclusion bodies in Escherichia coli. These inclusion body proteins are stable to proteolytic degradation until they are solubilized by denaturation. The protease that degrades them under denaturing conditions was identified as OmpT on the basis of substrate specificity, inhibitor profile, and confirmation that its N-terminal sequence is identical with that of OmpT. A previously unknown property of this enzyme, OmpT's preference for denatured substrates, may provide a clue to its physiological function. To facilitate further characterization of this proteolytic activity, we have optimized a system to extract and assay OmpT under denaturing conditions using a soluble substrate, rabbit muscle creatine kinase.
In this study we typed HLA-A polymorphisms by a new sequence-based typing (SBT) method, which involved one PCR reaction and four sequencing reactions covering exon 2 and exon 3. This method allowed complete identification of all known HLA-A alleles and revealed the presence of a new allele, named HLA-A*2608. We also introduced sequencing of exon 4 for some samples in order to discriminate the allelic pairs that are identical in exon 2 and 3, thus improving SBT resolution. Finally, we compared the results obtained by SBT with data obtained by serological typing and the amplification refractory mutation system (ARMS-PCR). Together, our results suggest that the SBT here described provides an optimal HLA-A typing technique that may be useful in selecting donor-recipient pairs in bone marrow transplantation between unrelated individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.